$0.6717
0.011.93%
At close: -
$0.6777
0.006000.89%
After Hours: Feb 14, 7:56 PM EDT
Comments
Loading...
Elevation Oncology (NASDAQ:ELEV) Stock, Earnings Estimates, EPS, And Revenue
Elevation Oncology reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 5
EPS Estimate
$-0.230
Quarterly Revenue Estimate
–
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Elevation Oncology using advanced sorting and filters.
Data brought to you by Benzinga APIs
Elevation Oncology (ELEV) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-06 | $-0.22 | $-0.20 | -10.0 % |
| Q2 | 2024-08-06 | $-0.18 | $-0.22 | 18.2 % |
| Q1 | 2024-05-02 | $-0.23 | $-0.20 | -15.0 % |
| Q4 | 2024-03-06 | $-0.19 | $-0.23 | 17.4 % |
Elevation Oncology (ELEV) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Elevation Oncology (NASDAQ:ELEV) reporting earnings?
Elevation Oncology (ELEV) is scheduled to report earnings on May 1, 2025. The last reported earnings were for reported on November 6, 2024 for Q3.
What were the latest earnings per share (EPS) for Elevation Oncology (NASDAQ:ELEV)?
The Actual EPS was $-0.22, which missed the estimate of $-0.20.
What were Elevation Oncology’s (NASDAQ:ELEV) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.